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Background: The optimal initial management of primary spontaneous pneumothorax (PSP)
remains controversial. This study was to evaluate the safety and efﬁcacy of intrapleural
minocycline following aspiration for initial treatment of PSP.
Methods: Between January 2004 and November 2006, 64 patients with a ﬁrst episode of
PSP were successfully treated by simple aspiration using pigtail or intravenous needle
catheter. From December 2005, 31 of the patients also received 300mg of minocycline
hydrochloride post lung expansion, instilled through the catheter into the pleural space
(minocycline group). The control group consisted of the ﬁrst 33 patients of the series who
had successfully undergone simple aspiration alone between January 2004 and December
2005.
Results: There was no signiﬁcant difference between the two groups in terms of
demographic data. Patients in the minocycline group had higher doses of meperidine
injection. The group hospitalization rates and mean hospital stays were comparable. After
a mean follow-up of 13 months (range 3–26), recurrence was noted in 4 of the minocycline
group and 11 of the control group (12.9% versus 33.3%, p ¼ 0.045). Subsequent
thoracoscopic surgery for the recurrent patients revealed that minocycline induced scant
loose adhesions which did not signiﬁcantly affect operation procedures. The long-term
pulmonary function and rates of residual pain for the two groups were comparable.Elsevier Ltd. All rights reserved.
ous pneumothorax.
23123456x5070; fax: +886 2 33933989.
(Y.-C. Lee).
ARTICLE IN PRESS
Aspiration and minocycline for spontaneous pneumothorax 1005Conclusions: Although associated with immediate chest pain, intrapleural minocycline
following simple aspiration is a simple, safe and convenient initial treatment for PSP that
may reduce the rates of ipsilateral recurrence.
& 2008 Elsevier Ltd. All rights reserved.Introduction
Primary spontaneous pneumothorax (PSP) most commonly
occurs in young, tall, lean males.1,2 The estimated recur-
rence rate is 23–50% after the ﬁrst episode.3–5 This high
recurrence rate has stimulated development of many
different therapeutic approaches, ranging from conserva-
tive treatment, such as observation, to more invasive
therapies, including surgery.6 Optimal treatment for pa-
tients presenting with a ﬁrst episode of PSP remains
controversial. In the recently published British Thoracic
Society (BTS) guidelines, simple aspiration is recommended
as the ﬁrst-line treatment for all PSP cases requiring
intervention because this treatment provides the advantage
of reduced hospital admission rate and decreased hospital
stay when compared with chest tube drainage.4 However,
the recurrence rate with this procedure is around 30%,
making it inappropriate as a standard of care.7,8
Intrapleural instillation of a chemical irritant (chemical
pleurodesis) is an effective way to reduce the rates of
recurrent spontaneous pneumothorax in surgical and non-
surgical patients.9–11 Previously, chemical pleurodesis has
typically been administered through chest tube or thoraco-
scopy.9–13 Administration of sclerosing agents through
intravenous needle or pigtail catheter after simple aspira-
tion has not previously been reported and, therefore, the
safety and efﬁcacy of this simple procedure remain
unknown.
As our recurrence rate after simple aspiration had
continued to remain high, we began to instill minocycline
into the pleural cavity through the pigtail or intravenous
needle catheter from December 2005 to determine if this
adjuvant was effective in terms of reducing the recurrence
rate. In the present study, we report our experience of
minocycline pleurodesis for treatment of a ﬁrst episode of
PSP after successful aspiration of pneumothorax. The effects
of this adjuvant therapy were evaluated by comparing the
outcomes for patients who underwent the simple aspiration
with or without additional minocycline pleurodesis.Patients and methods
Study design
The aims of this retrospective study were to evaluate the
safety and efﬁcacy of additional minocycline pleurodesis
after simple aspiration for preventing recurrence of a ﬁrst
episode of PSP. From January 2004 to December 2005,
nothing was administered to the pleural cavity after
successful aspiration of PSP (control group). Since December
2005, we began to instill minocycline through the aspirationcatheter to attempt to decrease the incidence of ipsilateral
recurrence of pneumothorax.
Patient selection and institutional review board
approval
From January 2004 to November 2006, all patients with the
diagnosis of spontaneous pneumothorax admitted to the
emergency department (ED) or general wards of a 2600-bed
university teaching hospital with an ED annual census of
around 100,000 patient-visits were identiﬁed. After careful
review of the medical records, only patients who underwent
manual aspiration as their initial treatment were selected.
To avoid cases of recurrent or secondary spontaneous
pneumothorax, patients with a previous history of sponta-
neous pneumothorax, aged over 50 years, or with preexist-
ing pulmonary diseases were excluded. Unsuccessful
aspiration requiring further chest tube insertion and
thoracoscopic surgery were additional exclusion criteria.
The selection criteria for patients with or without minocy-
cline pleurodesis were the same. This study was approved by
the Institutional Review Board of National Taiwan University
Hospital.
Manual aspiration and minocycline pleurodesis
Informed consent was obtained from all subjects before the
procedure. Manual aspiration was performed as follows:
patients were seated in semi-supine position. After skin
disinfection and ﬁeld preparation, a small-caliber Teﬂon
intravenous needle (Surﬂo, 16 or 18Ga; Terumo Corpora-
tion, Tokyo, Japan) or pigtail catheter (six or eight French;
Bioteque Corporation, I-Lan, Taiwan) was introduced into
the second or third intercostal space, at the midclavicular
line, after local anesthesia with 2% lidocaine. After the
catheter had entered the pleural space, it was ﬁxed to the
skin using sterile adhesive tape and connected via a three-
way valve to a 50-ml syringe. Air was manually aspirated,
until a resistance was felt and aspiration ceased. Thereafter,
chest radiography (CXR) was performed with the catheter in
place. If the CXR conﬁrmed that there was no pneumothorax
or only a very small one with improvement of symptoms,
then the patient was admitted to the ER observation unit or
the general ward for observation or minocycline pleurod-
esis. Pneumothoraces that failed to resolve after aspiration
were treated by chest tube drainage or thoracoscopic
surgery, at the discretion of the attending physicians.
Pleurodesis patients received 30ml of 1% lidocaine
hydrochloride (300mg) followed by a solution of 30ml of
normal saline containing 300mg of minocycline (Mirosins;
Taiwan Panbiotic Laboratories, Kaohsiung, Taiwan) instilled
into the pleural cavity through the intravenous needle or
pigtail catheter. Patients were repositioned every 30min so
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Side effects and complaints were recorded. CXR at 4–6 h
after aspiration with/without minocycline administration
was evaluated, with the catheter removed when complete
expansion of the lung or only a very small rim of apical air
detected in all cases.
Estimation of pneumothorax size
The CXR was carefully reviewed in each case and
the pneumothorax size estimated using Light’s formula
(estimated pneumothorax percentage ¼ (1L3/H3) 100;
where H ¼ mean hemothorax diameter and L ¼ mean
diameter of lung ‘‘collapse’’).14
Pulmonary function analysis
Pulmonary function tests were performed for non-recurrent
patients able to attend a hospital outpatient appointment at
least 6 months after aspiration. Forced vital capacity (FVC)
and forced expiratory volume in 1 s (FEV1.0) were measured
using a spirometer (Microspiro HI-298; Chest Corporation,
Tokyo, Japan) in the seated position. A minimum of three
acceptable forced expiratory maneuvers were performed,
with the best selected for analysis.
Data collection and analysis
The data, including patient demographics, radiographic size
of pneumothorax, volume of air aspirated, hospitalization
rates, duration of observation, complications, and operative
ﬁndings and results, were collected through retrospective
chart review and documentation of database information.
Follow-up was in the form of clinical visits or telephone
conversation; interval range was 3–26 months (mean 13).
Residual pain was evaluated for non-recurrent patients at
least 6 months after aspiration on a 0–5 pain scale, with the
integers representing freedom from pain, occasional dis-
comfort, occasional analgesia, non-opiate analgesia, opiates
for regular pain, and severe and intractable pain, respec-
tively.15 Continuous variables, such as age and weight, are
expressed as mean7standard deviation, with the two-
sample t-test used for analysis. Categorical variables,
including gender and smoking status, are presented asTable 1 Clinical characteristics of patients with and without a
Minocycline group (N ¼ 31
Age (year) 22.778.1
Sex (male) 28 (90.3%)
BMI,y 19.171.2
Smoking 15 (48.4%)
Side involved (left) 17 (54.8%)
Pneumothorax size (%),z 53.7716.1
Aspirated volume (ml) 867.17395.6
Mean7S.D.
yBMI, body mass index.
zEstimated by Light’s formula.frequency (%) and analyzed by Fisher’s exact test. Scores for
residual chest pain were analyzed using the Wilcoxon rank-
sum test. The Kaplan–Meier method was used to evaluate
freedom from recurrence, and the log-rank test was applied
for comparisons. A p-value of less than 0.05 was considered
signiﬁcant for all tests.
Results
Between 2004 and 2006, a total of 93 patients with
spontaneous pneumothorax were managed by simple aspira-
tion using pigtail (n ¼ 69) or intravenous needle catheter
(n ¼ 24) at our ED. Of these, 29 individuals were excluded
from the study because of: age (450 years; n ¼ 2);
preexisting pulmonary disease (n ¼ 1); unsuccessful aspira-
tion (n ¼ 24); or, loss to follow-up after treatment (n ¼ 2). Of
the remaining 64 subjects, 34 underwent simple aspiration
alone while 31 underwent additional minocycline pleurodesis
before catheter removal. There were no signiﬁcant between-
group differences comparing demographic data, pneumothor-
ax size, or aspirated volume (Table 1). The treatment results
are summarized in Table 2. No procedure-related complica-
tions were observed in either group. Chest pain was a
common complaint after minocycline instillation, with severe
pain that required immediate meperidine injection occurring
in 12 patients (38.7%) in the minocycline group but only 2
(6.1%) of the controls (p ¼ 0.002). The mean accumulated
dose of meperidine was also higher for the minocycline
group (48.3mg versus 16.7mg; p ¼ 0.029). Five minocycline
patients were admitted for 1–3 days for wound pain (n ¼ 1),
incomplete absorption of pneumothorax (n ¼ 1), or observa-
tion only (n ¼ 3). Four of the controls were admitted for 1–4
days for incomplete absorption of pneumothorax (n ¼ 1) or
observation only (n ¼ 3). Group hospitalization rates and
mean duration of observation are comparable.
After a mean follow-up of 13 months (range 3–26),
recurrent ipsilateral pneumothorax was noted in four
minocycline patients (12.9%) and 11 controls (33.3%)
(p ¼ 0.045, Kaplan–Meier method and log-rank test). The
rates of freedom from recurrence (Kaplan–Meier method)
for both groups are plotted in Figure 1. The divergence of
the two curves almost immediately after aspiration in-
dicates that patients in the minocycline group had a lower
rate of recurrence and greater latency. Twelve out of 14
recurrent patients (minocycline group: 3, observationdditional minocycline pleurodesis after aspiration.
) Observation group (N ¼ 33) p-Value
23.778.1 0.616
25 (75.8%) 0.186
19.272.2 0.940
10 (30.3%) 0.200
20 (60.6%) 0.801
54.8714.0 0.763
909.17578.0 0.737
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Table 2 Treatment results for patients with and without additional minocycline pleurodesis.
Minocycline group (N ¼ 31) Observation group (N ¼ 33) p-Value
Meperidine requested 12 (38.7%) 2 (6.1%) 0.002
Dose of meperidine (mg) 48.375.8 16.7725.8 0.029
Complication 0 (0%) 0 (0%) 1.000
Hospitalization 5 (16.1%) 4 (12.1%) 0.729
Duration of observation (h) 23.2717.6 24.2718.9 0.830
Recurrence 4 (12.9%) 11 (33.3%) 0.077
Pulmonary function test,y
FVCz 98.2712.0 98.7711.1 0.904
FEV1.0
z 98.5712.2 103.079.5 0.246
Residual painy
Pain free 18 (69.2%) 15 (83.3%) 0.294
Occasional discomfort 8 (30.8%) 3 (16.7%)
Occasional use of analgesics 0 (0%) 0 (0%)
FVC, force vital capacity; FEV1.0, force expiratory volume in 1 s.
Mean7S.D.
yTwenty patients in the minocycline group and 15 in observation group were available for spirometric measurement.
zFVC and FEV1.0 are presented as percentage of predictive value.
yTwenty-six patients in the minocycline group and 18 in the observation group were available for residual pain evaluation, and
analyzed by Wilcoxon rank-sum test.
Figure 1 Freedom from recurrent pneumothorax in patients with or without additional minocycline pleurodesis after simple
aspiration. The number of patients at risk for each 6-month period is indicated under the corresponding time point.
Aspiration and minocycline for spontaneous pneumothorax 1007group: 9) subsequently underwent thoracoscopic bullectomy
and mechanical pleurodesis, with no complications occur-
ring. The surgical ﬁndings and results for both groups were
comparable in terms of blood loss, surgical duration, and
postoperative stay (Table 3). On thoracoscopy, two minocy-
cline patients (66.7%) had pleural adhesions, while no
adhesions were noted in the controls (p ¼ 0.045). Theadhesions were scant and loose, and mainly located in the
anterior superior pleural cavity where the minocycline was
instilled (Figure 2). The adhesions were easily freed using
endoscopic instruments and did not signiﬁcantly affect
thoracoscopic procedures and outcomes.
To evaluate the long-term effects of minocycline pleur-
odesis in terms of pulmonary function and chest pain, 35
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Table 3 Operation ﬁndings and results for recurrent patients with or without additional minocycline pleurodesis.
Minocycline group (N ¼ 3) Observation group (N ¼ 9) p-Value
Age (year) 25.078.1 22.878.1 0.755
Sex (male) 3 (100%) 7 (77.8%) 40.99
Smoking 2 (66.7%) 2 (22.2%) 0.236
Pleural adhesions 2 (66.7%) 0 (0%) 0.045
Blood loss (ml) 76.7725.5 66.7731.2 0.629
Duration of operation (min) 88.3733.3 78.9734.6 0.643
Postoperative stay (day) 4.071.0 3.871.1 0.763
Mean7S.D.
Figure 2 Pleural adhesions in a recurrent patient after
minocycline instillation. C: chest wall; L: lung.
J.-S. Chen et al.1008patients were available for spirometric measurement and 44
for residual pain evaluation (20/15 and 26/18 in the
minocycline/observation groups, respectively). The results
show that the two groups had comparable FVC and FEV1.0.
Most patients were pain free. Only 11 individuals experi-
enced occasional discomfort during the follow-up period,
however, analgesics were not required. Group scores for
residual chest pain were also comparable (Table 2).
Discussion
This study demonstrates that minocycline pleurodesis
following simple aspiration provides a safe, easy, noninva-
sive, and convenient initial treatment for PSP that may
reduce the rates of recurrence.
The initial management of PSP has been a subject of
controversy. Choice of initial treatment includes observa-
tion,4 simple aspiration,5,8,16–18 chest tube drainage,4,5,7
chest tube drainage with sclerosis,9,13 medical thoraco-
scopy,12 and video-assisted thoracoscopic surgery (VATS).19
Among the published methods, prevention of recurrence can
only be obtained by chest tube drainage with sclerosis,
medical thoracoscopy, or VATS. However, VATS is not
suggested as the initial treatment for PSP by most physicians
because it results in 70% of patients undergoing unnecessary
operations. Talcage via medical thoracoscopy for PSP is more
cost-effective than chest tube drainage12; however, admis-
sion is required and the procedure must be performed by aspecialist. Because of the invasiveness and inconvenience of
the available methods, there is quite good consensus that
procedures to prevent recurrence should be reserved for the
second pneumothorax.4–6
In their prospective randomized trial, Light et al. showed
that intrapleural tetracycline instillation is effective for
diminishing the rate of recurrence for patients with
spontaneous pneumothorax who are hospitalized and trea-
ted with tube thoracostomy.9 Further, tetracycline pleurod-
esis decreased the recurrence rate from 31.8% to 10.5% and
from 43.0% to 28.2% in patients with PSP and secondary
spontaneous pneumothoraces, respectively. Another rando-
mized study comparing the pneumothorax recurrence after
chest tube drainage without and with tetracycline found
recurrence rates of 36% and 13%, respectively.13 Our
recurrence rates for simple aspiration alone or with
minocycline pleurodesis (33.3% and 12.9%) are similar to
those of the above two studies, indicating that tetracycline-
based pleurodesis remains effective regardless of whether
administration is via chest tube or aspiration catheter.
The most commonly used methods for air evacuation are
simple aspiration and chest tube drainage. These is now
compelling evidence that simple aspiration should be
considered the primary treatment in uncomplicated PSP
because it appears to be as effective as chest tube
drainage.7,8,17,18 Further, compared to the latter, the
advantages of reduced hospital admission rate and de-
creased stay associated with simple aspiration translate into
economic beneﬁts.16,21 Furthermore, placement of an
aspiration catheter is easier than a chest tube, with the
complication rate also lower.4,22 In addition to demonstrat-
ing the safety of simple aspiration in PSP, our data also show
that minocycline can be easily administered through the
aspiration catheter without increasing the complication rate
and hospital stay.
Although chemical pleurodesis is effective in terms of
reducing the rate of recurrence, the recently published
guidelines do not recommend it as the initial treatment for
PSP because pleural adhesions may interfere with subse-
quent surgery in the event of recurrence, and operation
remains the standard of care in recurrent patients.4,5 In our
cohort, three recurrent patients in the minocycline group
underwent thoracoscopic bullectomy and apical pleurect-
omy. Although scant, loose adhesions were noted intrasurgi-
cally in two of these cases, these did not affect the
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blood loss and postoperative stay were comparable to
analogous control patients who did not undergo minocycline
pleurodesis. A possible explanation for this ﬁnding is that
minocycline induces variety degrees of pleural adhesions,
with recurrence only occurring in patients with loose or no
adhesions.
In this study, minocycline was selected for the chemical
pleurodesis because this tetracycline derivative is compar-
ably safe, inexpensive and widely available. Minocycline
also compares favorably with tetracycline in terms of
demonstrated efﬁcacy of pleurodesis in a lapin model.20
Most importantly, minocycline hydrochloride is easily ad-
ministered through aspiration catheters of very small
caliber. In contrast, talc is not suitable for delivery via
pigtail or intravenous needle catheter. Although talc may
have a lower recurrence rate, it must be applied surgically
or thoracoscopically, and admission is required.12
Another concern with minocycline pleurodesis is the risk
of constrictive pulmonary dysfunction after minocycline
instillation. Our study showed that the long-term FVC
and FEV1.0 data for the two treatment groups were
comparable, suggesting minocycline pleurodesis does not
cause signiﬁcant impairment of pulmonary function after
simple aspiration.
Chest pain was the most common complaint associated
with minocycline pleurodesis.10,11 Although an intrapleural
dose of 300mg of lidocaine had been administered before
minocycline instillation, our results show that meperidine
was immediately required in 39% of the patients. Addition-
ally, the mean meperidine dose was signiﬁcantly higher in
the minocycline group. However, the group scores for long-
term residual chest pain were low and similar, suggesting
that minocycline pleurodesis was not associated with higher
incidence of residual chest pain. In general, minocycline
instillation proved safe in our sample, with no pleural
effusions or infections noted.
We accept that this was a retrospective investigation,
with comparison based on a historical control; nevertheless,
our results show that minocycline pleurodesis can be easily
and safely applied after successful simple aspiration for PSP
without increasing hospital stay or complication rates. In
addition, minocycline pleurodesis does not appear to affect
subsequent treatment when surgical intervention is re-
quired. As our results also suggest that minocycline
following simple aspiration may decrease the rates of
pneumothorax recurrence, further prospective randomized
trials are needed to rigorously test the efﬁcacy of this
method as the initial treatment for PSP.Conﬂict of interest statement
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